Title : The Vildagliptin Experience - 25 Years Since the Initiation of the Novartis Glucagon-like Peptide-1 Based Therapy Programme and 10 Years Since the First Vildagliptin Registration.

Pub. Date : 2017 Aug

PMID : 29632608






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The studies establish that vildagliptin is a selective DPP-4 inhibitor that blocks GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) inactivation, thereby prolonging their action, resulting in improved glycaemic control. Vildagliptin gastric inhibitory polypeptide Homo sapiens
2 The studies establish that vildagliptin is a selective DPP-4 inhibitor that blocks GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) inactivation, thereby prolonging their action, resulting in improved glycaemic control. Vildagliptin gastric inhibitory polypeptide Homo sapiens